Genetic variations in ZFP36 and their possible relationship to autoimmune diseases

Journal of Autoimmunity

Volumn 26, Issue 3, 2006, Pages 182-196

  Carrick, Danielle Mercatante ^a   Chulada, Patricia ^a   Donn, Rachelle ^c   Fabris, Martina ^d   McNicholl, Janet ^e   Whitworth, William ^e   Blackshear, Perry J ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF UDINE   (Italy)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Autoimmune disease; Genetic association; Polymorphisms; Tristetraprolin; Tumor necrosis factor alpha

Indexed keywords

TRISTETRAPROLIN;

ADULT; AFRICAN AMERICAN; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENTHESITIS; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; POLYARTERITIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RACE DIFFERENCE; RHEUMATOID ARTHRITIS;

ADULT; ALLELES; AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; ETHNIC GROUPS; HAPLOTYPES; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TRISTETRAPROLIN; VARIATION (GENETICS);

EID: 33646680556     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.01.004     Document Type: Article

References (47)

1. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14 (1996) 397-440
2. Feldmann M. The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target. J R Coll Physicians Lond 30 (1996) 560-570
3. Brennan F.M., and Feldmann M. Cytokines in autoimmunity. Curr Opin Immunol 8 (1996) 872-877
4. Feldmann M., Brennan F.M., and Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 17 (1998) 217-228
5. Tutuncu Z., Morgan Jr. G.J., and Kavanaugh A. Anti-TNF therapy for other inflammatory conditions. Clin Exp Rheumatol 20 (2002) S146-S151
6. Bondeson J., and Maini R.N. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE). Int J Clin Pract 55 (2001) 211-216
7. Abuzakouk M., Feighery C., and Jackson J. Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders. Br J Biomed Sci 59 (2002) 173-179
8. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., and Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19 (1999) 4311-4323
9. Blackshear P.J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30 (2002) 945-952
10. Carrick D.M., Lai W.S., and Blackshear P.J. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res Ther 6 (2004) 248-264
11. Taylor G.A., Lai W.S., Oakey R.J., Seldin M.F., Shows T.B., Eddy Jr. R.L., et al. The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes. Nucleic Acids Res 19 (1991) 3454
12. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 (1996) 445-454
13. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10 (1991) 4025-4031
14. Ulich T.R., Shin S.S., and del Castillo J. Haematologic effects of TNF. Res Immunol 144 (1993) 347-354
15. Carballo E., and Blackshear P.J. Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome. Blood 98 (2001) 2389-2395
16. Dooley M., and Hogan S. Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol 15 (2003) 99-103
17. Guengerich F. The Environmental Genome Project: functional analysis of polymorphisms. Environ Health Perspect 107 (1998) 365-368
18. Blackshear P.J., Phillips R.S., Vazquez-Matias J., and Mohrenweiser H. Polymorphisms in the genes encoding members of the tristetraprolin family of human tandem CCCH zinc finger proteins. Prog Nucleic Acid Res Mol Biol 75 (2003) 43-68
19. Fabris M., Tolusso B., Di Poi E., Assaloni R., Sinigaglia L., and Ferraccioli G. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis. J Rheumatol 29 (2002) 1847-1850
20. Ferraccioli G., Assaloni R., Di Poi E., Gremese E., De Marchi G., and Fabris M. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Rheumatology (Oxford) 41 (2002) 1109-1112
21. Donn R., Alfouri Z., Zeggini E., Lamb R., Jury F., Lunt M., et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 50 (2004) 1604-1610
22. Weatherby S.J., Thompson W., Pepper L., Donn R., Worthington J., Mann C.L., et al. HLA-DRB1 and disease outcome in multiple sclerosis. J Neurol 248 (2001) 304-310
23. Donn R., Farhan A., Stevans A., Ramanan A., Ollier W.E., Thompson W., et al. Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Rheumatology (Oxford) 41 (2002) 930-936
24. Bridges S.J., Hughes L., Mikuls T., Howard G., Tiwari H., Alarcon G., et al. Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol 21 (2003) S138-S145
25. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31 (2004) 390-392
26. Reese M.G., Eeckman F.H., Kulp D., and Haussler D. Improved splice site detection in Genie. J Comput Biol 4 (1997) 311-323
27. MatInspector. http://www.genomatix.de/products/MatInspector/MatInspector1.html MatInspector Matrix Library, Version 4.1
28. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F.C., Blackwell T.K., et al. MK2-induced tristetraprolin: 14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 23 (2004) 1313-1324
29. Chrestensen C., Schroeder M., Shabanowitz J., Hunt D., Pelo J., Worthington M., et al. MAPKAP Kinase 2 phosphorylates Tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279 (2004) 10176-10184
30. Taylor G.A., Thompson M.J., Lai W.S., and Blackshear P.J. Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem 270 (1995) 13341-13347
31. Phillips R.S., Ramos S.B.V., and Blackshear P.J. Members of the tristetraprolin family of tandem CCCH zinc finger proteins exhibit CRM1-dependent nucleocytoplasmic shuttling. J Biol Chem 277 (2002) 11606-11613
32. Blom N., Gammeltoft S., and Brunak S. Sequence and structure based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294 (1999) 1351-1362
33. PhosphoBase.
34. Prosite.
35. Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
36. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
37. Ke X., and Cardon L. Efficient selective screening of haplotype tag SNPs. Bioinformatics 19 (2003) 287-288
38. Schneider S., Roessli D., and Excoffier L. Arlequin: A software for population genetics data analysis. Ver 2.000. Genetics and Biometry Laboratory (2000), University of Geneva, Switzerland
39. Johnson B.A., Stehn J.R., Yaffe M.B., and Blackwell T.K. Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. J Biol Chem 277 (2002) 18029-18036
40. Bridges D., and Moorhead G.B. 14-3-3 proteins: a number of functions for a numbered protein. Sci STKE (2004) Pubmed In Progress
41. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., et al. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91 (1997) 961-971
42. Tajima F. Evolutionary relationship of DNA sequences in finite populations. Genetics 105 (1983) 437-460
43. Nei M. Molecular evolutionary genetics (1987), Columbia University Press, New York, NY, USA
44. Li W., and Sadler L. Low nucleotide diversity in man. Genetics 129 (1991) 513-523
45. Carlson C., Eberle M., Rieder M., Yi Q., Kruglyak L., and Nickerson D. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74 (2004) 106-120
46. Jacobson D., Gange S., Rose N., and Graham N. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84 (1997) 223-243
47. Fernandez J., Yaman I., Huang C., Liu H., Lopez A.B., Komar A.A., et al. Ribosome Stalling Regulates IRES-Mediated Translation in Eukaryotes, a Parallel to Prokaryotic Attenuation. Mol Cell 17 (2005) 405-416